Wright U.S. Recon Sales Falter, But Firm Has High Hopes For Evolution Knee
This article was originally published in The Gray Sheet
Executive Summary
Wright Medical is looking to its newly launched, next generation Evolution medial-pivot primary knee system to help restore domestic reconstructive sales to growth, the firm said during an Aug. 2 second-quarter earnings call
You may also be interested in...
Hip, Knee Sales Growth Slows In Second Quarter For Top Orthopedic Firms
Overall weakness in the hip-and-knee market resulted in low-single-digit reconstructive sales growth for Zimmer, Stryker and Johnson & Johnson/DePuy in the second quarter
With PMA Approval, Wright's Conserve Plus Hip System Resurfaces
FDA approved Wright Medical's Conserve Plus hip resurfacing system, the firm announced Nov. 9, six years after the product's PMA application was originally submitted
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.